Total Funding
$1.2B
Employee Range
251-500
This company uses cutting-edge technology to develop new treatments for deadly diseases by combining biology, engineering, and chemistry.
Eikon Therapeutics data powered by:
Share
Eikon Therapeutics data powered by:
Eikon TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of unicorns
Regional Rank
Share
Loading...
In North America
Top null%out of unicorns
Eikon TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
1st
In Hayward
Top 100%out of 1 unicorns
National Rank
Share
27th
In United States
Top 50%out of 54 unicorns
Regional Rank
Share
27th
In North America
Top 50%out of 54 unicorns
Eikon TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Hayward
Top 100%out of 1 unicorns
National Rank
Share
4th
In United States
Top 37%out of 11 unicorns
Regional Rank
Share
4th
In North America
Top 37%out of 11 unicorns
Special Awards
Unicorn
Reached a US$ 1 billion valuationrankings by:
Eikon TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Eikon TherapeuticsunicornComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro